Bangor Savings Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
ACA
Bangor Savings Bank's XBI Position: Q1 2024 in Review
Bangor Savings Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 200 shares — an estimated $17.9K sold.
Bangor Savings Bank first reported a position in XBI in Q2 2022 and held it in 7 quarters. The position peaked at $17.9K in Q4 2023. 782 funds tracked by Wall St. Rank hold XBI as of Q1 2024.
- Bangor Savings Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
- Bangor Savings Bank sold 200 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $17.9K.
- Bangor Savings Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 7 quarters.
- Bangor Savings Bank's State Street SPDR S&P Biotech ETF position peaked at $17.9K in Q4 2023.
- 782 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.
Based on Bangor Savings Bank's 13F filing for Q1 2024, filed 11 Apr 2024.